Protein That Boosts Longevity May Protect Against Diabetes
A new MIT study has found that a protein that slows aging in mice and other animals also helps fight against the damages of a high-fat diet, including diabetes.
Over a decade ago, SIRT1’s longevity-boosting properties were discovered by MIT biology professor Leonard Guarente, who has continued to examine its role in various body tissues. His recent study, appearing August 8th in the journal Cell Metabolism, observed what happens when the SIRT1 protein is missing from adipose cells, which make up body fat.
The research team put mice on a high-fat diet and realized that they started to develop metabolic disorders, like diabetes, when they lacked the protein, while normal mice given the same diet did not develop these disorders as quickly.
Guarente, the Novartis Professor of Biology at MIT, explained:
“We see them as being poised for metabolic dysfunction. You’ve removed one of the safeguards against metabolic decline, so if you now give them the trigger of a high-fat diet, they’re much more sensitive than the normal mouse.”
This finding suggests that drugs that enhance SIRT1 activity could possibly help fight against obesity-linked diseases.
While the expert studied yeast in the 1990s, he first discovered the effects of SIRT1 and other sirtuin proteins. These proteins have since shown to help keep cells alive and healthy by coordinating a variety of hormonal networks, regulatory proteins, and other genes.
In order to pinpoint the gene’s effects more accurately, Guarente and his team deleted the gene from organs such as the brain and the liver. Their past research has shown that in the brain, SIRT1 protects against the neurodegeneration seen in Huntington’s, Alzherimer’s, and Parkinson’s diseases.
SIRT1 is a protein that is known for removing acetyl groups from other proteins while modifying their activity. According to Guarente, the possible targets of this deacetylation are numerous, allowing SIRT1 to have its broad range of protective powers.
The hundreds of genes that were turned on in mice that were fed a normal diet lacking SIRT1 were analyzed by the team. They found that they were almost identical to those genes turned on in normal mice that were given a high-fat diet.
These results suggest that the development of metabolic disorders is a two-step process in normal mice. He said, “This first step is inactivation of SIRT1 by the high-fat diet, and the second step is all the bad things that follow that.”
The scientists wanted to investigate how this occurs and discovered that in normal mice fed a high-fat diet, the SIRT1 protein is cleaved by an enzyme (caspase-1), which is induced by inflammation. They were already aware that inflammation can develop from high-fat diets, though it is still unknown how that exactly happens.
Tuberclosis(TB) being the infectious disease is communicated almost exclusively by coughed aerosols carrying pathogens of Mycobacterium tuberclosis (Mtb). As reported by World Health Organization (WHO) it causes disease in 9.6 millions people each year and ranks with human immunodeficiency virus (HIV) as a leading cause of disease. A well timed diagnosis and appropriate treatment can […]Read More »
A researcher at Moffitt Cancer Center and his international team of colleagues have reported study results on a novel multireceptor-targeted somatostatin analogue called pasireotide (SOM230) manufactured by Novartis Pharma AG. The Phase II, open-label, multicenter study in patients with advanced neuroendocrine tumors (NET) whose symptoms were no longer responsive to octreotide LAR therapy found that […]Read More »
In a large epidemiologic study, researchers at UCLA’s Jonsson Cancer Center found that the children of U.S.-born Latina women are at higher risk of having retinoblastoma, a malignant tumor of the retina which typically occurs in children under six. The study, which focused on babies born in California, also found that offspring of older fathers […]Read More »
Since June 2012, it is official: The World Health Organisation (WHO) has classified diesel soot as a lung carcinogen. Artur Braun, a physicist at Empa and an X-ray spectroscopy expert, has made crucial contributions to analyzing the structure and composition of soot particles. Soot particles are dangerous – there is nothing new in this knowledge. […]Read More »
A new clinical trial published in the August edition of Clinical Cancer Research has revealed that cancer patients who drink one glass of grapefruit juice per day achieve the same benefits from an anti-cancer drug as they would get from more than three times as much of the drug by itself. It could also help […]Read More »
On 14 February 2012, the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with heart failure. The aim of the report is to identify those recommendations from current guidelines of high methodological quality that may be […]Read More »
When combined with standard diagnostic tests, functional imaging procedures have been shown to reduce the rate of misdiagnosed cases of infectious endocarditis. According to new research published in the August issue of The Journal of Nuclear Medicine, single photon emission computed tomography (SPECT)/computed tomography (CT) with 99mTc-hexamethylpropleneamine oxime-labeled white blood cells (99mTc-HMPAO-WBC) can improve the […]Read More »
For years, scientists have been looking for a good source of heart cells that can be used to study cardiac function in the lab, or perhaps even to replace diseased or damaged tissue in heart disease patients. To do this, many are looking to stem cells. Researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham), the Human […]Read More »
A new genetic analysis focusing on Jews from North Africa has provided an overall genetic map of the Jewish Diasporas. The findings support the historical record of Middle Eastern Jews settling in North Africa during Classical Antiquity, proselytizing and marrying local populations, and, in the process, forming distinct populations that stayed largely intact for more […]Read More »
University of Minnesota School of Public Health researchers have found that medical group practices can reduce costs for patients with diabetes by investing in improved quality of care. In the study, which appears in the August issue of Health Affairs, University of Minnesota researchers analyzed 234 medical group practices providing care for more than 133,000 […]Read More »